Ketamine, traditionally an anesthetic, has emerged as a rapid-acting treatment for severe and treatment-resistant depression. Unlike conventional antidepressants that target monoamines like serotonin, ketamine primarily works by affecting the glutamate system, the brain's main excitatory neurotransmitter.